Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA037422 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA037422, RRID:AB_10672347
- Product name
- Anti-AXL
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AXL, Gene description: AXL receptor tyrosine kinase, Alternative Gene Names: JTK11, UFO, Validated applications: WB, Uniprot ID: P30530, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references A retrospective analysis of the correlation between AXL expression and clinical outcomes of patients with urothelial bladder carcinoma
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
Wang L, Liu K, Yu J, Sun E
Translational Cancer Research 2019;8(3):976-984
Translational Cancer Research 2019;8(3):976-984
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
Pinato D, Brown M, Trousil S, Aboagye E, Beaumont J, Zhang H, Coley H, Mauri F, Sharma R
British Journal of Cancer 2019;120(5):512-521
British Journal of Cancer 2019;120(5):512-521
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
Ong C, Chong P, McArt D, Chan J, Tan H, Kumar A, Chung M, Clément M, Soong R, Van Schaeybroeck S, Waugh D, Johnston P, Dunne P, Salto-Tellez M
Oncotarget 2015;6(14):12763-12773
Oncotarget 2015;6(14):12763-12773
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
Pinato D, Mauri F, Lloyd T, Vaira V, Casadio C, Boldorini R, Sharma R
British Journal of Cancer 2013;108(3):621-628
British Journal of Cancer 2013;108(3):621-628
No comments: Submit comment
No validations: Submit validation data